29973-97-5

29973-97-5 structure
29973-97-5 structure
  • Name: 2-[3-(Benzyloxy)phenyl]ethanamine hydrochloride (1:1)
  • Chemical Name: 2-[3-(Benzyloxy)phenyl]ethanamine hydrochloride (1:1)
  • CAS Number: 29973-97-5
  • Molecular Formula: C15H18ClNO
  • Molecular Weight: 263.76300
  • Create Date: 2018-07-11 21:35:37
  • Modify Date: 2024-01-10 13:47:51

Name 2-[3-(Benzyloxy)phenyl]ethanamine hydrochloride (1:1)
Synonyms 2-(3-(benzyloxy)phenyl)-2-methylpropanal
2-(3-Benzyloxyphenyl)-2-methylpropionaldehyd
3-Benzyloxy-phenaethylamin,Hydrochlorid
2-<3-(benzyloxy)phenyl>-2-methylpropionaldehyde
|A,|A-Dimethyl-3-(phenylmethoxy)benzeneacetaldehyde
3-benzyloxyphenethylamine hydrochloride
2-(3-benzyloxy-phenyl)-ethylamine hydrochloride
Boiling Point 370.1ºC at 760mmHg
Molecular Formula C15H18ClNO
Molecular Weight 263.76300
Flash Point 179.3ºC
Exact Mass 263.10800
PSA 35.25000
LogP 4.26910
Vapour Pressure 1.13E-05mmHg at 25°C

CHEMICAL IDENTIFICATION

RTECS NUMBER :
DA0341600
CHEMICAL NAME :
Benzeneethanamine, 3-(phenylmethoxy)-, hydrochloride
CAS REGISTRY NUMBER :
29973-97-5
LAST UPDATED :
199112
DATA ITEMS CITED :
1
MOLECULAR FORMULA :
C15-H17-N-O.Cl-H
MOLECULAR WEIGHT :
263.79

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
164 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold
REFERENCE :
RPTOAN Russian Pharmacology and Toxicology (English Translation). Translation of FATOAO. (Euromed Pub., 33, Woodlands Rd., Surbiton, Surrey, UK) V.30- 1967- Volume(issue)/page/year: 39,209,1976

~%

29973-97-5 structure

29973-97-5

Literature: Conte-Mayweg, Aurelia; Kuehne, Holger; Luebbers, Thomas; Maugeais, Cyrille; Mueller, Werner; Pflieger, Philippe Patent: US2006/30613 A1, 2006 ; Location in patent: Page/Page column 22 ;

~%

29973-97-5 structure

29973-97-5

Literature: Baxter, Ellen W.; Reitz, Allen B.; Parker, Michael H.; Huang, Yifang; Ho, Chih Yung; Strobel, Eric D.; Reynolds, Charles H. Patent: US2007/232630 A1, 2007 ; Location in patent: Page/Page column 18 ; US 20070232630 A1

~%

29973-97-5 structure

29973-97-5

Literature: Rigel Pharmaceuticals, Inc.; Goff, Dane; Payan, Donald G.; Braselmann, Sylvia Patent: US2013/237524 A1, 2013 ;

~%

29973-97-5 structure

29973-97-5

Literature: Santangelo Freel, Rose M.; Ogden, Kevin K.; Strong, Katie L.; Khatri, Alpa; Chepiga, Kathryn M.; Jensen, Henrik S.; Traynelis, Stephen F.; Liotta, Dennis C. Journal of Medicinal Chemistry, 2013 , vol. 56, # 13 p. 5351 - 5381

~%

29973-97-5 structure

29973-97-5

Literature: Santangelo Freel, Rose M.; Ogden, Kevin K.; Strong, Katie L.; Khatri, Alpa; Chepiga, Kathryn M.; Jensen, Henrik S.; Traynelis, Stephen F.; Liotta, Dennis C. Journal of Medicinal Chemistry, 2013 , vol. 56, # 13 p. 5351 - 5381